FR99C0035I1 - - Google Patents

Info

Publication number
FR99C0035I1
FR99C0035I1 FR99C0035C FR99C0035I1 FR 99C0035 I1 FR99C0035 I1 FR 99C0035I1 FR 99C0035 C FR99C0035 C FR 99C0035C FR 99C0035 I1 FR99C0035 I1 FR 99C0035I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP20963184A external-priority patent/JPS6187619A/en
Priority claimed from JP16289385A external-priority patent/JPS6226223A/en
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of FR99C0035I1 publication Critical patent/FR99C0035I1/fr
Application granted granted Critical
Publication of FR99C0035I2 publication Critical patent/FR99C0035I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
FR99C0035C 1984-10-08 1999-09-30 Active FR99C0035I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20963184A JPS6187619A (en) 1984-10-08 1984-10-08 Activated vitamin d3 for external use
JP16289385A JPS6226223A (en) 1985-07-25 1985-07-25 Remedy for psoriasis

Publications (2)

Publication Number Publication Date
FR99C0035I1 true FR99C0035I1 (en) 1999-11-05
FR99C0035I2 FR99C0035I2 (en) 2000-08-11

Family

ID=26488518

Family Applications (1)

Application Number Title Priority Date Filing Date
FR99C0035C Active FR99C0035I2 (en) 1984-10-08 1999-09-30

Country Status (6)

Country Link
US (1) US4871723A (en)
EP (1) EP0177920B1 (en)
CA (1) CA1272953A (en)
DE (1) DE3579655D1 (en)
FR (1) FR99C0035I2 (en)
MY (1) MY101544A (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728643A (en) * 1984-11-02 1988-03-01 The General Hospital Corporation Method of treating psoriasis
US5037816A (en) * 1984-11-02 1991-08-06 The General Hospital Corporation Method of treating psoriasis
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
JP2856444B2 (en) * 1989-07-28 1999-02-10 呉羽化学工業株式会社 Vitamin D lower 3 metabolite preparation
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
ATE104554T1 (en) * 1990-01-10 1994-05-15 Hoffmann La Roche TOPICAL PREPARATIONS.
AU7474291A (en) * 1990-03-02 1991-09-18 Partnership of Isaac G. Eliaz and Shmuel Gonen, The Method and product for promoting hair growth and treating skin conditions
US6203782B1 (en) 1990-03-02 2001-03-20 Universal Biologics, Inc. Method and product for promoting hair growth and treating skin conditions
ES2070307T3 (en) * 1990-07-04 1995-06-01 Marcin Krotkiewski A PREPARATION FOR THE TREATMENT OF HYPERTENSION.
AU653026B2 (en) * 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
EP0581587A3 (en) * 1992-07-31 1995-05-17 Tanabe Seiyaku Co Base for transdermal administration.
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
WO1995006482A1 (en) * 1993-09-01 1995-03-09 Teijin Limited 1α,24-(OH)2-VITAMIN D3 EMULSION COMPOSITION
FR2710841B1 (en) * 1993-10-05 1995-11-17 Oreal Cosmetic or pharmaceutical composition for the skin, anhydrous and stable, based on retinol and its use for the treatment of skin diseases.
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
AU710931B2 (en) * 1996-02-28 1999-09-30 Sumitomo Pharmaceuticals Company, Limited Crystalline vitamin D derivative
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
EP1051974A4 (en) * 1997-12-09 2001-09-12 Chugai Pharmaceutical Co Ltd Lotions containing vitamin d 3 derivatives
US6491936B1 (en) 1997-12-09 2002-12-10 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
KR20010032892A (en) * 1997-12-09 2001-04-25 나가야마 오사무 Creams containing vitamin d3 derivatives
ES2245511T3 (en) * 1998-03-04 2006-01-01 Teijin Limited VITAMIN LOANS D3 ACTIVE IN THE FORM OF EMULSION.
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
FR2871694B1 (en) * 2004-06-17 2008-07-04 Galderma Sa PHARMACEUTICAL COMPOSITION COMPRISING OLEAGINOUS OINTMENT AND TWO SOLUBILIZED ACTIVE INGREDIENTS
FR2884419B1 (en) * 2005-04-19 2007-06-22 Galderma Sa A FILMOGENOUS SOLUTION COMPOSITION COMPRISING VITAMIN D OR ONE OF ITS DERIVATIVES AND A CORTICOSTEROID, AND ITS USE IN DERMATOLOGY
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
CN101193641B (en) 2005-05-10 2013-05-29 德米普瑟尔有限公司 Compositions and methods for treating hyperproliferative epidermal diseases
FR2885527B1 (en) * 2005-05-16 2007-06-29 Galderma Res & Dev PHARMACEUTICAL COMPOSITION COMPRISING AN OLEAGINOUS OINTMENT AND VITAMIN D OR ITS DERIVATIVES IN THE SOLUBILIZED CONDITION
NZ563560A (en) 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
SI2686017T1 (en) 2011-03-14 2019-11-29 Drug Delivery Solutions Ltd An ophthalmic composition
JP5652723B2 (en) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド New crystal form of maxacalcitol
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) * 1963-11-01 1966-05-03 Maeth Harry Topical dressing
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
DE2249414A1 (en) 1972-10-09 1974-04-25 Georg Dr Rueckheim Burn ointment contg. vitamin D3 - together with calcium phosphate, zinc oxide, olive oil and Balsam of Peru
US3901928A (en) 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US4022891A (en) 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
FR2389377A1 (en) * 1977-05-06 1978-12-01 Brohult Johan Antiinflammatory, antirheumatic medicament - comprises 1 alpha-hydroxy-cholecalciferol
JPS5452717A (en) * 1977-09-29 1979-04-25 Chugai Pharmaceut Co Ltd Stable oily pharmaceuticals containing 1alpha-hydroxyvitamin d
US4230701A (en) * 1979-03-21 1980-10-28 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
JPS5626820A (en) 1979-08-10 1981-03-16 Chugai Pharmaceut Co Ltd Immunosuppressing agent
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
JPS57149224A (en) 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4338312A (en) * 1981-05-11 1982-07-06 Wisconsin Alumni Research Foundation Method for preventing parturient paresis in dairy cattle
US4442093A (en) * 1981-05-15 1984-04-10 Kureha Kagaku Kogyo Kabushiki Kaisha Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
IL68695A (en) 1982-05-17 1986-01-31 Sparamedica Ag Pharmaceutical compositions containing 24,24-difluoro-1alpha,25-dihydroxy-cholecalciferol active against osteoporosis and in the prevention of milk fever
US4428946A (en) 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
IT1163846B (en) * 1982-07-26 1987-04-08 Wisconsin Alumni Res Found VITAMIN D ANALOGS
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
JPS59184135A (en) 1983-04-04 1984-10-19 Teijin Ltd Medicinal composition containing glycerol pyroglutamate
JPS6011422A (en) * 1983-06-30 1985-01-21 Kureha Chem Ind Co Ltd Antimyodystrophic agent
JPS6160620A (en) * 1984-09-03 1986-03-28 Teijin Ltd Pharmaceutical composition containing pyroglutamic acid ester
JPS6217A (en) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd Stable active type vitamin d3 pharmaceutical

Also Published As

Publication number Publication date
US4871723A (en) 1989-10-03
EP0177920A3 (en) 1987-06-03
EP0177920A2 (en) 1986-04-16
EP0177920B1 (en) 1990-09-12
FR99C0035I2 (en) 2000-08-11
DE3579655D1 (en) 1990-10-18
CA1272953A (en) 1990-08-21
MY101544A (en) 1991-12-17

Similar Documents

Publication Publication Date Title
FR99C0035I2 (en)
DE8500973U1 (en)
DE3424906C2 (en)
DE3415551C2 (en)
AT379850B (en)
DE3440907C2 (en)
DE3437432C2 (en)
DE3417067C2 (en)
DE3426556C2 (en)
DE8431416U1 (en)
DE3444476C2 (en)
DE3425878C2 (en)
DE8417096U1 (en)
AU2219783A (en)
GR73384B (en)
GR76606B (en)
AU2557584A (en)
GR77398B (en)
BG45105A1 (en)
BG45166A1 (en)
BG45296A1 (en)
BE900712A (en)
BG45280A1 (en)
BG45134A1 (en)
BG45279A1 (en)